Allspring Global Investments Holdings LLC Sells 33,161 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Allspring Global Investments Holdings LLC lessened its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 10.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 284,547 shares of the company's stock after selling 33,161 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.45% of Guardian Pharmacy Services worth $6,049,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. GAMMA Investing LLC bought a new stake in shares of Guardian Pharmacy Services in the first quarter valued at about $170,000. Nuveen Asset Management LLC lifted its stake in Guardian Pharmacy Services by 2.9% in the 4th quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company's stock valued at $11,085,000 after acquiring an additional 15,550 shares in the last quarter. Occudo Quantitative Strategies LP acquired a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $455,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $98,000. Finally, Lazard Asset Management LLC grew its stake in shares of Guardian Pharmacy Services by 0.5% during the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock worth $3,865,000 after acquiring an additional 860 shares in the last quarter.

Insider Activity at Guardian Pharmacy Services

In other news, Director Thomas J. Salentine, Jr. sold 651,454 shares of the firm's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the completion of the transaction, the director owned 1,939,817 shares of the company's stock, valued at approximately $39,106,710.72. This trade represents a 25.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider David K. Morris sold 68,547 shares of the business's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $1,381,907.52. Following the completion of the transaction, the insider owned 214,495 shares in the company, valued at approximately $4,324,219.20. The trade was a 24.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,344,912 shares of company stock worth $228,713,426 over the last 90 days. 63.71% of the stock is currently owned by company insiders.

Guardian Pharmacy Services Stock Down 0.7%

Shares of GRDN traded down $0.15 during mid-day trading on Monday, hitting $20.70. 273,448 shares of the company's stock were exchanged, compared to its average volume of 186,000. Guardian Pharmacy Services, Inc. has a 52 week low of $14.16 and a 52 week high of $26.91. The stock's 50-day simple moving average is $22.30 and its 200-day simple moving average is $21.50.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Equities research analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on GRDN shares. Raymond James Financial set a $28.00 price target on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a research report on Wednesday, May 14th. Wall Street Zen lowered Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Truist Financial restated a "buy" rating and issued a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.